STEVENSVILLE, Md., July 12, 2011 /PRNewswire-USNewswire/ —
Vapotherm, a privately held manufacturer of respiratory care
devices for hospital and home use, announced today that it has
signed a new exclusive distribution agreement with Hippo Medical of
Seoul, Korea. Hippo will cover all of Korea for the Vapotherm
acute care product line.
“We are pleased to announce this new partnership with Hippo to
bring high flow therapy to the Korean market,” said Steve Orwig,
Acute Care Manager with Vapotherm. “We had several options
for our distribution in Korea, but we ultimately selected Hippo
based on the professionalism of their sales and marketing
organization and the enthusiasm they share for the large market
potential for high flow in the market.”
Hwang Se Jung, Vice President at Hippo Medical, commented,
“Hippo is pleased to represent the Vapotherm line in Korea, where
we see strong potential for high flow therapy. Vapotherm
brings us clear clinical and technical leadership in high flow
therapy, with innovative products like Precision Flow®, the
only device in the category to integrate flow, gas blending and
humidification control in one device for cost effective,
non-invasive respiratory support via nasal cannula.”
Hippo Medical was founded in 1976 and specializes in importing,
marketing and distributing premium, innovative medical technologies
to hospitals and clinicians. Their product line includes
airway management and other critical care technologies from
manufacturers such as Covidien, Medis and Arcomed. For more
information, visit www.hippomedical.co.kr.
Vapotherm, Inc. is a privately held manufacturer of respiratory
care devices for hospitals and home care use based in Stevensville,
Maryland. The Company is dedicated to the development of
innovative, noninvasive technologies for respiratory therapy,
especially for the treatment of chronic lung and acute breat
‘/>”/>
